The US Institute for Safe Medication Practices considers insulin to be one of the top 5 ‘high-alert’ medications i.e. drugs that bear a heightened risk of causing significant patient harm when they are used in error.
Recent Posts
- Speech by Minister Simon Coveney to the IMSN conference in UCC on 24th November 2023
- IMSN Medication Safety Bulletin & other published material
- Building a Medication Safety Programme in a Hospital in Ireland: Fundamental Steps
- Lithium-Prescribing & Monitoring (Best Practice Guidelines and Patient Information)
- Direct Oral Anticoagulants (DOACs) (Safety Alert & Patient Resources)